In its first-quarter presentation, Sanofi highlighted that it has a “vigorous defense planned” to extend Dupixent’s exclusivity beyond March of 2031, when the U.S. patent protecting its compound expires. The blockbuster accounted for 40% of the company's sales in Q1.
With the recent launch of Novo Nordisk’s Wegovy pill opening the oral GLP-1 market for obesity, the company has now unveiled positive results that could tee up an expansion in semaglutide’s inaugural diabetes indication.
Nearly two-thirds of Americans are using artificial intelligence-based tools to seek medical information, while about one-third do not trust them.
Evonik plans to spend €80 million ($93.5 million) to upgrade its bio fermentation production technology in Slovenská Ľupča, Slovakia, as part of an expansion that will add 50 new jobs.
A rare group of adults over 80, known as SuperAgers, are rewriting what we thought was possible for the aging brain. With memory abilities comparable to people decades younger, their brains either resist or withstand the damage typically linked to Alzheimer’s disease. Decades of research reveal that their social lifestyles and unique brain biology may hold the key to preserving cognitive function.
Scientists have identified two specific types of brain cells that behave differently in people with depression, offering a clearer picture of what is happening inside the brain. By analyzing donated brain tissue with advanced genetic tools, the researchers found changes in neurons linked to mood and stress, as well as in immune-related microglia cells. These differences point to disruptions in key
Deerfield Group has launched software designed to help pharma brand marketing teams keep sales reps on message.
Merck & Co.’s $1 billion deal with Google Cloud is seeking to bolster its AI credentials—and the U.S. Big Pharma has some big plans for its commercial teams.
A new minimally invasive procedure may help people keep weight off after stopping popular drugs like Ozempic and semaglutide—something most patients struggle with. In a clinical trial, those who underwent a technique called duodenal mucosal resurfacing regained far less weight compared to others after discontinuing the medication. The procedure works by renewing the lining of the upper small intes
A new virus-fighting plastic film could transform everyday surfaces into invisible defenders against disease. Instead of relying on chemicals, this flexible material is covered in microscopic pillars that physically stretch viruses until they burst, rendering them harmless. In lab tests, it destroyed or disabled about 94% of virus particles within an hour, showing impressive effectiveness.
Kennedy continues to make waves across health care, but he's pulled back on a number of core MAHA issues.
A new Medicare prior authorization test is delaying care at Washington state hospitals – and should be scrapped, senator says.
Naming a former Imperial Brands executive for a CDC job is the latest example, advocates say, of tobacco industry influence in Trump administration.
Scientists at UC Irvine have found a way to potentially reverse age-related vision loss by targeting the ELOVL2 “aging gene” and restoring vital fatty acids in the retina. Their experiments in mice show that supplementing with specific polyunsaturated fatty acids—not just DHA—can restore visual function and even reverse cellular aging signs.
At AACR, there was talk of Chinese biotech's place in cancer research, oncology’s comms issue, and more.
Watch RFK Jr. testify live before the Senate's health care panel.
Suicide rates among young people dropped 11% after the U.S. launched the 988 national suicide and crisis hotline, a new study shows
Like with many other pharma giants, AbbVie's manufacturing expansion will see the company put down roots in North Carolina.
The Trump administration is delaying a voluntary model that aimed to expand access to GLP-1s in Part D after pushback from insurers.
The industry is entering “the golden era for biosimilars,” Amneal co-CEO Chirag Patel said Wednesday morning as he explained the motivation for his company’s $1.1 billion acquisition of Kashiv BioSciences.